Cargando…

FAM46C/TENT5C functions as a tumor suppressor through inhibition of Plk4 activity

Polo like kinase 4 (Plk4) is a tightly regulated serine threonine kinase that governs centriole duplication. Increased Plk4 expression, which is a feature of many common human cancers, causes centriole overduplication, mitotic irregularities, and chromosomal instability. Plk4 can also promote cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kazazian, Karineh, Haffani, Yosr, Ng, Deanna, Lee, Chae Min Michelle, Johnston, Wendy, Kim, Minji, Xu, Roland, Pacholzyk, Karina, Zih, Francis Si-Wah, Tan, Julie, Smrke, Alannah, Pollett, Aaron, Wu, Hannah Sun-Tsi, Swallow, Carol Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431843/
https://www.ncbi.nlm.nih.gov/pubmed/32807875
http://dx.doi.org/10.1038/s42003-020-01161-3
_version_ 1783571663367962624
author Kazazian, Karineh
Haffani, Yosr
Ng, Deanna
Lee, Chae Min Michelle
Johnston, Wendy
Kim, Minji
Xu, Roland
Pacholzyk, Karina
Zih, Francis Si-Wah
Tan, Julie
Smrke, Alannah
Pollett, Aaron
Wu, Hannah Sun-Tsi
Swallow, Carol Jane
author_facet Kazazian, Karineh
Haffani, Yosr
Ng, Deanna
Lee, Chae Min Michelle
Johnston, Wendy
Kim, Minji
Xu, Roland
Pacholzyk, Karina
Zih, Francis Si-Wah
Tan, Julie
Smrke, Alannah
Pollett, Aaron
Wu, Hannah Sun-Tsi
Swallow, Carol Jane
author_sort Kazazian, Karineh
collection PubMed
description Polo like kinase 4 (Plk4) is a tightly regulated serine threonine kinase that governs centriole duplication. Increased Plk4 expression, which is a feature of many common human cancers, causes centriole overduplication, mitotic irregularities, and chromosomal instability. Plk4 can also promote cancer invasion and metastasis through regulation of the actin cytoskeleton. Herein we demonstrate physical interaction of Plk4 with FAM46C/TENT5C, a conserved protein of unknown function until recently. FAM46C localizes to centrioles, inhibits Plk4 kinase activity, and suppresses Plk4-induced centriole duplication. Interference with Plk4 function by FAM46C was independent of the latter’s nucleotidyl transferase activity. In addition, FAM46C restrained cancer cell invasion and suppressed MDA MB-435 cancer growth in a xenograft model, opposing the effect of Plk4. We demonstrate loss of FAM46C in patient-derived colorectal cancer tumor tissue that becomes more profound with advanced clinical stage. These results implicate FAM46C as a tumor suppressor that acts by inhibiting Plk4 activity.
format Online
Article
Text
id pubmed-7431843
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74318432020-08-27 FAM46C/TENT5C functions as a tumor suppressor through inhibition of Plk4 activity Kazazian, Karineh Haffani, Yosr Ng, Deanna Lee, Chae Min Michelle Johnston, Wendy Kim, Minji Xu, Roland Pacholzyk, Karina Zih, Francis Si-Wah Tan, Julie Smrke, Alannah Pollett, Aaron Wu, Hannah Sun-Tsi Swallow, Carol Jane Commun Biol Article Polo like kinase 4 (Plk4) is a tightly regulated serine threonine kinase that governs centriole duplication. Increased Plk4 expression, which is a feature of many common human cancers, causes centriole overduplication, mitotic irregularities, and chromosomal instability. Plk4 can also promote cancer invasion and metastasis through regulation of the actin cytoskeleton. Herein we demonstrate physical interaction of Plk4 with FAM46C/TENT5C, a conserved protein of unknown function until recently. FAM46C localizes to centrioles, inhibits Plk4 kinase activity, and suppresses Plk4-induced centriole duplication. Interference with Plk4 function by FAM46C was independent of the latter’s nucleotidyl transferase activity. In addition, FAM46C restrained cancer cell invasion and suppressed MDA MB-435 cancer growth in a xenograft model, opposing the effect of Plk4. We demonstrate loss of FAM46C in patient-derived colorectal cancer tumor tissue that becomes more profound with advanced clinical stage. These results implicate FAM46C as a tumor suppressor that acts by inhibiting Plk4 activity. Nature Publishing Group UK 2020-08-17 /pmc/articles/PMC7431843/ /pubmed/32807875 http://dx.doi.org/10.1038/s42003-020-01161-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Kazazian, Karineh
Haffani, Yosr
Ng, Deanna
Lee, Chae Min Michelle
Johnston, Wendy
Kim, Minji
Xu, Roland
Pacholzyk, Karina
Zih, Francis Si-Wah
Tan, Julie
Smrke, Alannah
Pollett, Aaron
Wu, Hannah Sun-Tsi
Swallow, Carol Jane
FAM46C/TENT5C functions as a tumor suppressor through inhibition of Plk4 activity
title FAM46C/TENT5C functions as a tumor suppressor through inhibition of Plk4 activity
title_full FAM46C/TENT5C functions as a tumor suppressor through inhibition of Plk4 activity
title_fullStr FAM46C/TENT5C functions as a tumor suppressor through inhibition of Plk4 activity
title_full_unstemmed FAM46C/TENT5C functions as a tumor suppressor through inhibition of Plk4 activity
title_short FAM46C/TENT5C functions as a tumor suppressor through inhibition of Plk4 activity
title_sort fam46c/tent5c functions as a tumor suppressor through inhibition of plk4 activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431843/
https://www.ncbi.nlm.nih.gov/pubmed/32807875
http://dx.doi.org/10.1038/s42003-020-01161-3
work_keys_str_mv AT kazaziankarineh fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT haffaniyosr fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT ngdeanna fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT leechaeminmichelle fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT johnstonwendy fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT kimminji fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT xuroland fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT pacholzykkarina fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT zihfrancissiwah fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT tanjulie fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT smrkealannah fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT pollettaaron fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT wuhannahsuntsi fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity
AT swallowcaroljane fam46ctent5cfunctionsasatumorsuppressorthroughinhibitionofplk4activity